Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",23927,85,1.70 [0.92-3.16],0.0926716405827134
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",24428,130,1.28 [0.76-2.16],0.3469428772390329
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",24216,887,1.62 [1.35-1.94],1.401265176235077e-07
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Candidiasis,24454,264,1.90 [1.45-2.49],3.896125796135572e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23755,2406,1.55 [1.37-1.74],3.1622798627830897e-13
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23979,1817,1.50 [1.31-1.72],8.813412305308319e-09
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,24271,862,1.36 [1.12-1.64],0.0018499784770823
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,24382,38,1.60 [0.68-3.73],0.2788329804114487
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,23339,562,2.19 [1.78-2.69],1.497242324249069e-13
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22547,530,2.23 [1.77-2.81],1.4831106919164225e-11
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22776,150,2.71 [1.89-3.91],7.585094826288998e-08
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18182,1060,1.54 [1.29-1.85],2.957386010022394e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,22572,250,1.62 [1.13-2.34],0.0091724766094759
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,24417,1008,1.40 [1.17-1.67],0.0002083274976293
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Mycoses,24512,322,1.83 [1.41-2.37],5.757908832997722e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23870,541,1.92 [1.57-2.34],2.4506588330116767e-10
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24458,616,2.08 [1.70-2.55],1.956868382105926e-12
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,23541,132,1.26 [0.75-2.12],0.3874757969636894
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,24553,29,1.03 [0.33-3.20],0.9631956506269476
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other septicaemia,24385,543,2.20 [1.78-2.71],1.595927510153364e-13
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,24410,66,1.29 [0.62-2.68],0.4991126057101648
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other viral diseases,24463,155,1.49 [0.96-2.31],0.0737535153416429
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",24448,140,1.48 [0.93-2.36],0.0943025966817011
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,23633,304,1.51 [1.10-2.08],0.0118592158762309
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,23536,207,1.24 [0.82-1.88],0.3041930539562251
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,23476,67,2.18 [1.31-3.64],0.0028716877791476
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,24526,46,2.43 [1.45-4.08],0.0007934319039662
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,24496,114,1.27 [0.74-2.18],0.3916495988853248
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Viral warts,24420,38,1.13 [0.43-3.00],0.8065437080767418
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],24426,44,0.91 [0.35-2.33],0.8430420337310771
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm,24295,281,1.18 [0.82-1.70],0.362571223941955
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,24476,67,1.02 [0.48-2.17],0.9555296423134354
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,24448,68,1.20 [0.58-2.49],0.6249512920373471
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,10956,37,0.90 [0.31-2.63],0.850817176846394
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",24376,1026,0.99 [0.81-1.20],0.9184144385754216
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of meninges,24541,44,0.61 [0.23-1.58],0.3056042854382749
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,24521,49,1.35 [0.58-3.12],0.4825653552960577
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,24532,78,0.77 [0.37-1.56],0.4633807375864979
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm of ovary,13540,85,0.85 [0.43-1.67],0.6354844424980552
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Ascending colon,24545,241,0.92 [0.61-1.38],0.6918409064925332
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Caecum,24541,180,1.06 [0.67-1.68],0.8131414173559149
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",24488,48,0.64 [0.25-1.60],0.3356029192388832
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Descending colon,24547,155,0.84 [0.51-1.39],0.5009719142981806
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Rectum,24516,253,0.86 [0.58-1.28],0.4516687914742444
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,24484,473,1.04 [0.78-1.39],0.7714053264153475
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Benign neoplasm: Transverse colon,24545,268,1.11 [0.76-1.61],0.5975708047054289
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Carcinoma in situ of breast,11617,76,1.25 [0.64-2.46],0.509518635256391
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",11656,85,0.94 [0.48-1.85],0.8504394040152692
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",21187,31,3.93 [2.56-6.05],4.0433375191514366e-10
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",21190,34,2.34 [1.24-4.44],0.0088008747262204
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",24513,96,1.82 [1.15-2.90],0.010897127470743
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Haemangioma, any site",24513,94,1.79 [1.12-2.86],0.0157151509975261
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Leiomyoma of uterus,12968,358,0.84 [0.61-1.16],0.2954003980092528
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Lung cancer and mesothelioma,18203,157,1.11 [0.67-1.84],0.6970179234246545
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Lymphoid leukaemia,21184,28,3.36 [2.10-5.40],4.99703207068407e-07
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",21288,132,1.15 [0.68-1.95],0.6084531762243958
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",21233,77,1.03 [0.51-2.10],0.9298340226441416
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",11705,70,1.32 [0.66-2.60],0.4308140947475272
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",21201,45,2.89 [1.69-4.95],0.0001119463778631
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",21208,52,2.59 [1.48-4.53],0.0008895580639942
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",21220,64,2.14 [1.12-4.07],0.0210947707141728
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",11685,50,1.20 [0.53-2.69],0.6661788837042876
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",21207,51,0.41 [0.17-1.01],0.051388106675314
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",9874,353,0.93 [0.66-1.32],0.6874271138982438
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",21242,86,1.37 [0.72-2.60],0.3342268350218581
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",21204,48,1.44 [0.61-3.37],0.4062578371521601
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,21213,57,0.92 [0.40-2.12],0.8446815165155971
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi,24343,196,1.04 [0.67-1.61],0.8672079189523463
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanocytic naevi of trunk,24509,88,1.22 [0.64-2.32],0.5464336177198603
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Melanoma in situ,21166,40,1.53 [0.62-3.77],0.3543526719306729
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",21211,55,2.32 [1.38-3.89],0.0014242032761133
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",21260,104,2.02 [1.31-3.13],0.0015995155025241
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",21260,104,0.82 [0.44-1.53],0.5405153598271666
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",21216,60,2.15 [1.26-3.67],0.0047378780936712
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Other benign neoplasms of skin,24391,133,0.96 [0.56-1.65],0.8840875610362054
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",21723,567,1.00 [0.77-1.30],0.9924926266101836
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",21753,597,1.07 [0.83-1.38],0.5966779907869149
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,24300,268,1.88 [1.40-2.51],2.180265149415149e-05
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,23306,41,1.08 [0.41-2.83],0.8727493053143374
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,24099,67,1.59 [0.82-3.05],0.1671721119617131
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23839,1961,1.53 [1.34-1.74],1.2270351559806856e-10
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,23523,20,2.15 [0.71-6.53],0.1761668943769407
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,24239,27,2.94 [1.71-5.04],9.3735647226822e-05
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,24156,891,1.57 [1.30-1.89],3.293416040619705e-06
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,24156,891,1.57 [1.30-1.89],3.293416040619705e-06
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,23314,49,2.28 [1.15-4.53],0.0188599793594165
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,24306,803,1.60 [1.33-1.93],9.325808676509412e-07
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,24308,96,1.53 [0.88-2.67],0.1313197310606962
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,24080,48,1.73 [0.83-3.58],0.1424204919690164
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,24071,39,2.07 [1.11-3.86],0.0222810465562888
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,24380,168,2.49 [1.90-3.27],3.473835301052433e-11
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,24482,61,2.30 [1.43-3.70],0.0006369318662905
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",24356,144,2.42 [1.79-3.28],1.1059813522501789e-08
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,23565,62,1.26 [0.61-2.61],0.5338319669588725
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21072,180,2.90 [2.01-4.17],9.75787223401671e-09
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22825,107,0.80 [0.44-1.48],0.4839622812121986
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22844,126,1.83 [1.06-3.15],0.0298568544573363
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,20924,32,2.75 [1.15-6.57],0.0233138338238771
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22780,64,1.97 [1.01-3.83],0.0468162633493536
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,22476,124,0.79 [0.45-1.38],0.400763665448492
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",24424,145,1.22 [0.74-2.01],0.4276900298846904
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,24326,47,1.85 [0.89-3.84],0.1012679939774597
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,24310,31,1.24 [0.41-3.72],0.7028390190398022
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,24186,1470,1.25 [1.07-1.46],0.0042953269058775
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,21988,1429,1.26 [1.08-1.47],0.0036009070232127
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",20931,39,1.71 [0.67-4.33],0.2595486910714722
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",23100,52,2.48 [1.35-4.56],0.0033930054080987
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,21059,167,1.24 [0.77-2.00],0.3744822768143262
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,20948,56,0.63 [0.27-1.50],0.2975604051321486
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,23015,2123,1.45 [1.27-1.65],2.998629559207194e-08
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,21000,108,1.94 [1.13-3.33],0.0167479544645648
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,21241,349,1.18 [0.85-1.65],0.3193705708204156
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,24468,231,0.96 [0.64-1.44],0.838960878474451
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,24330,93,0.44 [0.23-0.86],0.0157174476150704
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,20983,91,1.40 [0.75-2.64],0.2927419577989382
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20927,35,4.72 [2.84-7.85],2.290498394480833e-09
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,24177,1129,1.32 [1.11-1.58],0.0014870781331547
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21003,111,3.28 [2.35-4.59],3.5362638171260232e-12
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21028,136,1.93 [1.18-3.15],0.0083942341265724
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",21242,350,1.44 [1.04-1.99],0.0289059708302743
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,20947,55,3.38 [1.83-6.25],9.810838927038782e-05
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,24324,87,0.45 [0.22-0.89],0.0210829446617934
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,21157,265,1.84 [1.29-2.62],0.0008001004154761
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,21167,275,1.79 [1.27-2.52],0.0009317569741891
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,22404,52,1.42 [0.64-3.15],0.3868478431874489
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23930,3038,1.40 [1.26-1.57],1.250470069212852e-09
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,23073,25,1.40 [0.44-4.42],0.571414802844775
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,23099,51,1.67 [0.78-3.58],0.1843528557788845
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,24395,1719,1.02 [0.88-1.18],0.8028658580339944
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",24398,1716,1.01 [0.87-1.18],0.851512302719877
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,23079,31,1.19 [0.41-3.52],0.7481199156072948
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,24264,1093,1.07 [0.89-1.28],0.4951716354546557
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21685,793,2.01 [1.65-2.46],4.444193245689618e-12
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,24545,109,2.05 [1.38-3.04],0.0003524243188083
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,24309,30,1.87 [0.80-4.40],0.1508880825777057
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,23254,83,1.39 [0.73-2.65],0.3148112566973307
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,23273,102,1.01 [0.55-1.87],0.9734547454540884
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",21005,113,1.72 [1.01-2.92],0.0445728328557254
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22955,108,2.60 [1.82-3.73],1.8634358562660215e-07
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1517,58,1.70 [0.77-3.75],0.1849209092368934
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1614,168,1.07 [0.68-1.70],0.764971787181369
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,22882,35,2.33 [0.97-5.57],0.0580613390309816
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1490,31,3.00 [1.11-8.13],0.0307040751980451
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,24188,1341,2.02 [1.76-2.31],1.6606709211216478e-23
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,24341,62,1.26 [0.59-2.70],0.5540006958540188
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,22602,250,1.52 [1.10-2.10],0.0102022190978849
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,21253,361,1.71 [1.26-2.32],0.0005844041851815
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",24472,152,1.16 [0.71-1.88],0.5543145999027825
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),23884,48,2.96 [1.67-5.26],0.0002099066153544
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Angina pectoris,23424,710,1.57 [1.26-1.95],5.584595618591009e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Aortic aneurysm,23929,93,2.52 [1.59-4.01],9.31283927643977e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,23864,28,1.91 [0.72-5.08],0.1940468320404171
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",23932,96,1.93 [1.21-3.09],0.0060191533462115
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17428,810,1.62 [1.32-1.99],3.213623986868841e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,AV-block,22341,161,1.12 [0.69-1.84],0.6400668552263058
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",24523,227,1.00 [0.67-1.51],0.9853268679883708
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cardiac arrest,16715,97,2.08 [1.32-3.30],0.001733106518663
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cardiomyopathy,22297,117,1.11 [0.62-1.96],0.7294090886663224
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",22255,75,1.16 [0.58-2.35],0.6718916611048333
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,24555,15,0.92 [0.19-4.33],0.9146995007708558
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Conduction disorders,22656,476,1.55 [1.20-2.02],0.0009766078415823
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23902,1198,1.65 [1.40-1.94],1.890474226393981e-09
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22811,5399,1.30 [1.19-1.41],5.24469586852615e-10
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,DVT of lower extremities,23527,160,1.41 [0.90-2.20],0.1350110875488101
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Endocarditis,22220,40,1.17 [0.44-3.12],0.7467845413931162
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24446,461,1.90 [1.50-2.41],9.19310809783516e-08
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertension,23319,4393,1.26 [1.15-1.38],4.390603468017545e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23327,4401,1.26 [1.15-1.38],6.588296683398549e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24397,48,4.07 [2.88-5.76],1.9873627106865195e-15
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19007,81,2.58 [1.76-3.77],9.922313081299826e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,18968,42,2.06 [1.03-4.13],0.0410789150902291
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypotension,24463,606,1.38 [1.10-1.74],0.0061163958910501
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,24082,57,1.31 [0.59-2.88],0.5091849268500315
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",24053,1339,1.52 [1.30-1.78],2.503996142993918e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",24353,276,1.15 [0.80-1.67],0.4426127712998519
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Left bundle-branch block,22365,185,1.60 [1.05-2.42],0.0269932510353223
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,24329,539,1.53 [1.19-1.95],0.0007625478920963
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",23153,439,1.67 [1.28-2.18],0.0001596324167065
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",24504,106,1.58 [0.90-2.76],0.1103308727525066
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",24540,185,1.69 [1.14-2.51],0.0091533791537259
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Oesophageal varices,23398,31,1.58 [1.10-2.28],0.0136433249212679
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other aneurysm,23878,42,0.80 [0.30-2.11],0.6504983493586327
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other arrhythmias,22407,227,1.30 [0.88-1.93],0.1889666463935338
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,23896,60,1.85 [1.03-3.32],0.0405454527198077
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,23968,132,1.93 [1.33-2.78],0.000471628590155
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,22293,113,1.55 [0.94-2.55],0.0832437175852611
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other disorders of veins,23430,63,1.04 [0.48-2.26],0.911468801543736
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,23412,45,2.05 [1.17-3.60],0.0120529977103923
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,23862,35,2.24 [0.97-5.15],0.0585499785858001
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,23449,82,1.07 [0.55-2.08],0.8395888176728405
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,22704,524,1.66 [1.31-2.12],3.580706730181776e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23898,41,3.28 [2.24-4.80],1.0144248572325122e-09
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,24143,307,1.71 [1.31-2.24],9.418791606711488e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,24145,139,2.29 [1.63-3.22],1.5863751404034204e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",24033,206,1.12 [0.73-1.71],0.6041408718166839
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16831,213,1.57 [1.07-2.29],0.0195513567849568
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Peripheral artery disease,23996,182,1.69 [1.18-2.43],0.0043556392346717
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),23588,221,1.14 [0.76-1.71],0.5364534497724989
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Pulmonary embolism,24308,302,1.20 [0.85-1.70],0.3010057584955516
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,24516,285,1.86 [1.39-2.49],3.1210392407259845e-05
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Right bundle-branch block,22331,151,1.84 [1.19-2.84],0.0057180229906806
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Secondary right heart disease,24142,136,2.30 [1.62-3.25],2.737271199967664e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,23931,104,1.52 [0.89-2.61],0.1274179313406809
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",24347,322,1.16 [0.83-1.63],0.3913978526731474
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",24324,355,1.14 [0.82-1.57],0.4330014729874931
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,24062,50,0.72 [0.30-1.76],0.4744088979343198
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,23886,51,2.30 [1.17-4.52],0.0161808483388516
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Transient ischemic attack,24197,120,0.96 [0.54-1.70],0.8981968662152857
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,23951,161,1.68 [1.08-2.60],0.0217028253123474
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Varicose veins,23641,274,1.16 [0.81-1.68],0.4189539379024881
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,23846,47,1.75 [0.92-3.35],0.0898250179546377
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Venous thromboembolism,24396,468,1.08 [0.81-1.43],0.6024107624912851
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",24408,333,1.09 [0.78-1.52],0.6149358196100847
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",21860,1256,1.11 [0.94-1.32],0.2093291957819037
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Any mental disorder,23876,3272,1.17 [1.05-1.30],0.0037259713852479
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",24353,387,1.03 [0.75-1.40],0.8604724658322425
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",22105,1501,1.29 [1.10-1.50],0.0011551281075696
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",20682,78,0.97 [0.48-1.96],0.9285477214192608
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Smoking dependency,24067,1366,1.20 [1.03-1.41],0.0217500100942854
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",22173,1569,1.19 [1.03-1.38],0.0209437149129717
CLSTN3,Calsyntenin-3,Chapter V Mental and behavioural disorders,Vascular dementia,24454,17,1.02 [0.22-4.67],0.9748125588003382
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Alzheimer disease,24554,65,1.40 [0.68-2.88],0.3564673154440564
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Bell's palsy,23068,66,1.25 [0.60-2.60],0.5580308622679031
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,23432,430,0.78 [0.58-1.06],0.1074013050888745
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Cerebral cysts,24234,181,1.32 [0.86-2.01],0.2014678014554846
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,24478,199,0.82 [0.52-1.28],0.3745221735810119
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,24421,22,1.77 [0.62-5.05],0.2827765787867164
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,24543,50,1.56 [0.70-3.49],0.2777707434690123
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",24105,52,1.13 [0.49-2.63],0.7720646142611083
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Epilepsy,23169,233,1.01 [0.67-1.52],0.9570979214697152
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,24120,1184,1.24 [1.04-1.48],0.0173981856788542
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,24527,170,1.59 [1.04-2.43],0.0326364067168483
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Falls/tendency to fall,24104,1474,1.19 [1.01-1.39],0.0332754022686018
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Generalized epilepsy,24221,48,1.09 [0.45-2.65],0.8547130453886423
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Hemiplegia,24426,147,0.95 [0.57-1.59],0.8434214424533143
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Hydrocephalus,24095,42,1.38 [0.60-3.17],0.4534636135683328
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,24532,61,1.49 [0.75-2.97],0.2563212192792077
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,23073,71,1.31 [0.67-2.57],0.4250449499172166
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,23075,73,1.11 [0.55-2.26],0.7671098582641358
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Memory loss,24421,66,0.93 [0.43-2.00],0.8538672553168997
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Migraine,23309,373,1.28 [0.94-1.74],0.1188313447017668
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",24475,337,1.28 [0.94-1.75],0.1134867074542807
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Motor neuron disease,17865,93,1.05 [0.55-2.02],0.8818216325630966
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,24358,131,0.92 [0.54-1.58],0.7644574520669005
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",24015,1013,1.04 [0.86-1.26],0.6860838828996336
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Neurological diseases,23262,2703,1.12 [1.00-1.27],0.0534668849606304
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,24466,67,1.18 [0.57-2.47],0.6529428478146004
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",23348,346,1.09 [0.79-1.51],0.5991150168867196
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",24491,202,1.94 [1.35-2.80],0.0003410585295666
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,20491,283,1.09 [0.75-1.57],0.6553022960777469
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,24107,54,0.81 [0.34-1.91],0.6230261537278595
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other disorders of nervous system,24159,106,0.96 [0.52-1.75],0.891010468261778
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,24431,74,1.34 [0.70-2.58],0.3717154410371642
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other facial nerve disorders,23086,84,1.32 [0.70-2.51],0.3922238348342425
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other headache syndromes,22992,56,0.97 [0.42-2.21],0.9357683355514158
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other neurological diseases,24446,393,1.03 [0.76-1.40],0.8442266639266393
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Other sleep disorders,23454,518,1.45 [1.12-1.89],0.0050059075089925
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Parkinson's disease,24541,75,1.71 [0.87-3.36],0.121260560810574
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,24109,56,1.42 [0.71-2.87],0.3212780550722367
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Restless leg syndrome,24553,34,2.03 [1.18-3.47],0.010110543244693
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Sleep apnoea,24334,449,1.44 [1.09-1.89],0.0099875374028345
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Small fibre neuropathy,24320,31,3.44 [2.12-5.57],5.768337770908417e-07
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,24539,118,0.82 [0.46-1.46],0.4956303532889127
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,23030,28,1.43 [0.51-4.03],0.4984978263455784
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,24554,66,1.41 [0.69-2.89],0.3411293204344249
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),24442,16,1.07 [0.23-5.08],0.9326607059081322
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,24127,36,1.11 [0.40-3.07],0.8391755118587368
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,24233,189,1.03 [0.66-1.62],0.8948585709278073
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,24477,171,1.98 [1.32-2.96],0.0009680073591102
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23883,34,0.52 [0.17-1.57],0.2475612876580502
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23917,68,0.67 [0.31-1.46],0.3142415646556375
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",24471,28,0.95 [0.30-3.05],0.9363879503685636
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,24388,57,1.77 [0.84-3.74],0.1365256822990512
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1493,34,3.20 [1.25-8.17],0.0149942667798122
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1769,69,1.64 [0.80-3.39],0.179377001718144
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,24165,74,1.63 [0.88-3.03],0.1192901511513175
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,24448,554,1.47 [1.15-1.88],0.0021685788053268
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",24271,422,0.97 [0.71-1.31],0.8296052622986416
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23971,122,1.01 [0.57-1.77],0.9788049029643424
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",24471,427,1.21 [0.90-1.63],0.1967259366260182
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,24546,50,0.67 [0.27-1.65],0.3818967336886995
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,24401,357,1.06 [0.76-1.47],0.721738519237928
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",24517,186,1.86 [1.26-2.74],0.0016230470548311
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,24496,120,1.20 [0.69-2.09],0.5158124650243585
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23864,15,1.70 [0.37-7.72],0.4928687006320021
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23875,26,0.95 [0.27-3.33],0.9356966879091732
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23878,29,0.65 [0.19-2.15],0.4759147169873897
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,24512,344,1.01 [0.72-1.41],0.976149993372886
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,24253,85,0.98 [0.50-1.94],0.9589011379517852
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,24066,22,2.06 [0.76-5.58],0.1553331983952574
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,24390,59,2.43 [1.41-4.20],0.0014794117743311
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,24460,129,1.51 [0.91-2.51],0.1115093347097232
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,24189,145,0.97 [0.57-1.64],0.908126649043038
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,24445,69,1.18 [0.57-2.47],0.6519213115932028
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,24393,225,1.16 [0.77-1.74],0.47241239590422
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,24190,99,1.30 [0.73-2.34],0.3713775822065644
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,23925,958,1.10 [0.90-1.34],0.3681123555069496
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,24439,108,1.64 [0.96-2.82],0.0711378964265567
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,24532,99,0.94 [0.50-1.76],0.8515404568585143
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,24081,232,1.17 [0.78-1.75],0.4502281339001454
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,24366,35,2.62 [1.29-5.31],0.0074019507301366
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,24530,34,0.49 [0.16-1.46],0.1991076390907303
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23885,36,0.67 [0.23-1.97],0.4635603328490923
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23950,101,0.94 [0.50-1.75],0.8376771202691891
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,23952,58,0.98 [0.43-2.24],0.9637400802353288
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,24095,51,1.81 [0.91-3.59],0.0915339077501816
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",23942,48,1.29 [0.54-3.09],0.5690260465048935
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,24216,48,0.61 [0.24-1.55],0.3003566026093034
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",24249,81,1.03 [0.52-2.07],0.9253781998282836
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23925,76,0.96 [0.47-1.99],0.9182095877881152
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,24001,107,1.49 [0.85-2.61],0.1615694905662697
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,23925,31,1.32 [0.46-3.83],0.6055712607953478
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,23701,734,1.29 [1.03-1.61],0.0255205705546531
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23894,45,0.74 [0.46-1.20],0.2217243477089549
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,24361,270,1.36 [0.96-1.93],0.0856628356977144
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,24123,32,1.70 [0.62-4.63],0.301525684243024
CLSTN3,Calsyntenin-3,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),24203,112,2.01 [1.31-3.07],0.0013142564075015
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,24370,56,0.61 [0.26-1.43],0.252323753736061
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,24513,82,0.63 [0.31-1.28],0.2054387358649521
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,24444,128,1.26 [0.76-2.09],0.3669921886843158
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,24365,51,1.10 [0.46-2.60],0.8308737506079373
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,24366,52,0.38 [0.16-0.93],0.0339543637240329
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,24470,480,1.26 [0.96-1.66],0.0937644432961833
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,24288,298,1.37 [0.97-1.93],0.0725291600872764
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,24077,87,0.90 [0.46-1.78],0.7717912061121034
CLSTN3,Calsyntenin-3,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,24059,69,0.68 [0.32-1.46],0.3253266445060645
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute pharyngitis,24291,69,0.95 [0.45-1.98],0.8826492500856087
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,24435,213,1.12 [0.75-1.69],0.5785855310454715
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,24280,58,0.69 [0.30-1.58],0.3820590231401434
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,All influenza,23402,69,2.10 [1.12-3.93],0.0202501830779925
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),23401,68,2.16 [1.16-4.03],0.0156200956027479
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Allergic asthma (mode),18167,121,1.17 [0.66-2.05],0.5930723138165401
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Allergic rhinitis,24426,280,1.03 [0.71-1.49],0.8799387087545262
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",19486,1574,1.25 [1.07-1.46],0.004613602882343
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",19589,1543,1.23 [1.05-1.44],0.0086560571433399
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),24303,85,2.21 [1.55-3.16],1.3455795471315196e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",23383,50,3.24 [1.88-5.60],2.500364942303469e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Bronchiectasis,21831,159,1.91 [1.32-2.76],0.0006368158932798
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",21706,34,0.82 [0.28-2.40],0.7192774893236762
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23772,2100,1.28 [1.13-1.45],0.0001354420418545
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",23236,60,1.17 [0.54-2.54],0.6870831981489136
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Chronic sinusitis,23322,146,1.52 [0.97-2.38],0.0695771511102773
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",24464,645,1.40 [1.13-1.72],0.0018192152452377
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Deviated nasal septum,23298,122,0.89 [0.50-1.57],0.6794232198305702
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22828,3787,1.27 [1.15-1.40],1.2520424420600077e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",23521,345,1.11 [0.80-1.54],0.5377820634763726
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Early onset COPD,24280,461,1.45 [1.16-1.81],0.0011513417187235
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Emphysema,21840,168,1.54 [1.11-2.12],0.009033071805873
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23401,102,1.16 [0.64-2.12],0.6228615709188301
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Influenza and pneumonia,24392,1059,1.67 [1.41-1.99],3.316119553335834e-09
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Interstitial lung disease,23422,123,1.48 [0.90-2.44],0.1239785759277958
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Later onset COPD,23251,184,1.22 [0.78-1.92],0.3755572233924422
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,24547,137,1.84 [1.21-2.79],0.0040784068397169
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Nasal polyp,23278,102,0.76 [0.41-1.43],0.4008584597219171
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,24359,566,1.65 [1.32-2.05],7.434235183584569e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of pleura,24390,1116,1.60 [1.37-1.87],4.291045884628903e-09
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23973,797,1.08 [0.87-1.34],0.4822577772977068
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other pleural conditions,23307,33,3.01 [1.98-4.58],2.2966433377881625e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24500,181,2.31 [1.68-3.18],2.680748351675603e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,24479,760,1.53 [1.26-1.86],1.677291490396454e-05
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural effusion,23810,536,1.93 [1.58-2.35],1.0565891273983164e-10
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural plaque,23323,49,2.37 [1.22-4.61],0.0110170514737894
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",24204,871,1.68 [1.39-2.03],6.608082081864296e-08
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,24530,120,1.91 [1.26-2.87],0.0020526606957862
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pneumothorax,23331,57,1.50 [0.72-3.11],0.276559835830055
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pollen allergy,24525,241,1.16 [0.79-1.71],0.4514913386818875
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pulmonary oedema,24355,36,4.13 [2.94-5.80],2.9464412502976825e-16
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Respiratory insufficiency,18079,33,0.78 [0.26-2.36],0.6585264941572009
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,24339,546,1.69 [1.36-2.10],2.53211865459758e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,23456,280,1.03 [0.71-1.49],0.8605128474938335
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Viral pneumonia,23498,165,1.15 [0.72-1.85],0.5610915375089311
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",24317,142,1.21 [0.73-2.00],0.4571302083914946
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,14143,87,0.94 [0.47-1.87],0.8577027075419386
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,18804,58,1.13 [0.52-2.49],0.7541225976276116
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute appendicitis,24374,136,1.47 [0.91-2.38],0.1142796457815891
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute gastritis,19625,62,1.02 [0.46-2.25],0.9663462399551412
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute pancreatitis,23119,153,1.00 [0.60-1.66],0.994481708503842
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Acute peritonitis,24151,61,1.81 [1.01-3.25],0.0460791529760761
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23868,77,2.40 [1.69-3.40],9.354978961498576e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Barrett oesophagus,19882,319,1.30 [0.93-1.82],0.1305512639207025
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",23015,49,3.06 [2.02-4.62],1.1543308998418189e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",24191,49,3.07 [2.03-4.66],1.233048846851374e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholecystitis,23122,156,1.14 [0.70-1.87],0.5950175840946492
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Cholelithiasis,23805,839,1.29 [1.06-1.58],0.0121096252378521
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic gastritis,19787,224,1.82 [1.32-2.49],0.0002250481890635
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Chronic pancreatitis,23002,36,2.39 [1.52-3.76],0.0001496855247544
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24424,75,3.56 [2.64-4.80],6.917860327449385e-17
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Coeliac disease,23276,98,2.25 [1.47-3.45],0.0001880288162868
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Collagenous colitis,23156,48,1.43 [0.63-3.24],0.3875501336377392
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,24382,183,1.01 [0.64-1.59],0.9695042939949216
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Constipation,24357,1027,1.30 [1.09-1.56],0.0044973906695262
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn disease,23191,83,1.61 [0.91-2.84],0.1030282099493239
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",24242,55,1.86 [0.96-3.61],0.0654238084738209
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Crohn's disease NAS,23186,78,1.85 [1.12-3.04],0.0160945301800897
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Dental caries,23811,233,1.17 [0.80-1.70],0.4207948047829557
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22684,1614,1.08 [0.92-1.26],0.3387026108456467
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of appendix,24412,174,1.40 [0.91-2.15],0.126190846308457
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of liver,24446,655,1.94 [1.62-2.32],4.724782564109046e-13
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",22998,3435,1.02 [0.92-1.13],0.7176633587394179
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",24118,540,1.19 [0.92-1.53],0.1831630865643754
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of peritoneum,24476,386,1.46 [1.10-1.93],0.0084760540187027
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23693,115,1.22 [0.71-2.10],0.4762103399500663
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23553,61,1.39 [0.68-2.82],0.3660532433095256
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of the digestive system,24302,1124,1.30 [1.09-1.55],0.0033046897051604
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of tongue,23559,107,0.92 [0.50-1.69],0.7938979878383974
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",24096,1130,1.30 [1.09-1.55],0.003033909389966
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,20908,2162,0.95 [0.83-1.09],0.4657965798960917
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Duodenal ulcer,19696,133,1.05 [0.61-1.81],0.8493872830509254
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",24488,102,1.25 [0.69-2.24],0.4616971232428954
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,24434,72,0.75 [0.35-1.59],0.4495974049306454
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23884,93,3.28 [2.48-4.34],8.889338050769241e-17
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,18904,158,0.99 [0.60-1.63],0.9703685598878946
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Functional dyspepsia,20021,458,0.91 [0.67-1.22],0.5161766405113177
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastric ulcer,19818,255,1.02 [0.69-1.50],0.9223548903906874
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,21567,2004,1.01 [0.88-1.16],0.8854678048135302
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,19934,371,1.05 [0.76-1.45],0.761567493874139
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,19993,7130,1.11 [1.03-1.19],0.0044270602508915
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,GI-bleeding,24080,902,1.14 [0.93-1.39],0.2167947244341972
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23639,61,1.77 [0.98-3.20],0.0591391324546744
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,19542,1123,1.03 [0.85-1.24],0.7582229586054201
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23836,45,2.91 [1.86-4.53],2.490553091276429e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Hernia,23502,2432,1.07 [0.94-1.21],0.3226241697747793
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Impacted teeth,24444,68,0.81 [0.38-1.74],0.5898042422636354
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Impaction of intestines,18778,32,1.80 [0.84-3.82],0.1287352914423846
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Inguinal hernia,21676,606,0.99 [0.76-1.29],0.9693503089980589
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",21141,71,0.82 [0.38-1.79],0.623792538985158
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,18811,65,0.70 [0.31-1.56],0.3812923534864169
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Intestinal malabsorption,23296,118,1.97 [1.28-3.03],0.0019025558773748
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,19260,514,1.01 [0.77-1.32],0.961997329415668
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24529,340,1.94 [1.51-2.49],2.761527657400661e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23733,625,1.23 [0.97-1.56],0.0930552329003324
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23894,786,1.27 [1.03-1.57],0.0252597129559656
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophageal obstruction,19694,131,1.51 [0.91-2.53],0.113110396067714
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oesophagitis,20000,437,1.39 [1.05-1.84],0.0200524302898354
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,24515,120,1.15 [0.66-2.01],0.6165975094372049
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,21114,44,0.52 [0.20-1.37],0.1852633624881328
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,19901,1155,1.12 [0.93-1.34],0.2353649101581253
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,23141,175,1.77 [1.21-2.59],0.0031988020235899
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,23107,141,0.91 [0.54-1.55],0.7365001540430456
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestine,20096,1350,1.13 [0.96-1.34],0.1448788972478072
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of intestines,23086,4340,1.11 [1.01-1.21],0.0332333410256517
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23558,174,1.16 [0.73-1.84],0.5271545719563739
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of liver,24318,527,1.96 [1.61-2.40],5.4084395293929615e-11
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20047,484,1.36 [1.04-1.77],0.0253436484058875
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of pancreas,23042,76,1.52 [0.79-2.93],0.2104236954119472
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,24428,338,1.37 [1.01-1.87],0.045089218879358
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,20244,681,1.35 [1.07-1.69],0.0101512673448698
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,24094,916,1.16 [0.95-1.42],0.1473139942167828
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23730,152,1.77 [1.24-2.52],0.0016711183868765
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,19818,1072,1.32 [1.10-1.57],0.0022957377624444
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),21135,1572,1.16 [0.99-1.35],0.0606926633319712
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23863,72,2.76 [1.87-4.08],3.769887199499602e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23791,683,1.24 [0.99-1.56],0.0651136804639121
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",18960,214,1.43 [0.97-2.11],0.0689202792724059
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,24418,84,0.75 [0.37-1.50],0.4150924499254195
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19062,316,1.41 [1.02-1.94],0.0372293702813343
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",23303,125,1.71 [1.08-2.70],0.0224386058986489
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Recurring oral aphthae,24546,55,1.77 [0.89-3.54],0.1044246273250743
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23591,116,1.53 [0.92-2.55],0.1006488108154883
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Toxic colitis,23131,23,1.69 [0.56-5.10],0.353866876046306
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,19737,174,1.28 [0.81-2.03],0.2919022400531107
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ulcerative colitis,23243,135,2.01 [1.38-2.93],0.0002767259728899
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",23225,117,2.01 [1.35-2.97],0.0005110339876576
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Umbilical hernia,21315,245,0.98 [0.66-1.46],0.9242237468053656
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,18843,97,1.05 [0.56-1.94],0.8854398753619316
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Ventral hernia,21278,208,1.50 [1.02-2.22],0.0405337810811364
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Volvulus,18805,59,1.19 [0.55-2.59],0.6549906880700738
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,24512,138,1.06 [0.62-1.82],0.8196540416546158
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,24314,75,1.74 [0.99-3.06],0.0537886704568455
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,23238,135,1.28 [0.78-2.11],0.3238847672310164
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23977,491,1.50 [1.15-1.95],0.002509592285758
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",23671,185,1.40 [0.94-2.09],0.1020297243700169
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,23254,151,1.49 [0.95-2.34],0.0805855754524769
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,24323,210,1.29 [0.87-1.93],0.2053277864063676
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,24465,352,1.50 [1.12-1.99],0.0058128423834474
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,24153,40,2.12 [1.20-3.73],0.0094167327572103
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,23251,2297,1.19 [1.05-1.35],0.0058529038470137
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,24141,384,1.00 [0.73-1.36],0.975220813582946
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,24027,270,1.06 [0.73-1.53],0.7721373404147193
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,24196,710,1.38 [1.12-1.72],0.0029052956788413
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",24542,41,1.23 [0.48-3.13],0.6654229203925437
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,23158,55,2.28 [1.48-3.54],0.000206897348938
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23795,38,1.49 [0.61-3.63],0.3780862779111059
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,24317,204,1.35 [0.90-2.02],0.1436889268550574
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,23367,264,1.21 [0.84-1.75],0.3114190771103297
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,23137,34,1.14 [0.40-3.28],0.8104977593739192
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,24478,66,1.25 [0.60-2.58],0.5470095451067603
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,23607,121,1.23 [0.71-2.14],0.4581200648829657
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,24376,137,1.30 [0.79-2.15],0.3058314333057603
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,24138,25,1.03 [0.30-3.56],0.9578065267287924
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,23151,48,0.42 [0.16-1.06],0.067193631026261
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,24099,996,1.20 [0.99-1.45],0.0592351659873052
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",23397,294,1.19 [0.84-1.69],0.3294140894300907
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,23140,37,1.12 [0.41-3.09],0.8214142049412811
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,24479,240,1.15 [0.78-1.70],0.4779820003739149
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,24167,54,2.13 [1.30-3.49],0.0026832548109142
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,24436,197,1.26 [0.83-1.90],0.2831704824989149
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,24527,153,1.08 [0.65-1.79],0.7658096624815373
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,23216,113,1.45 [0.86-2.43],0.1620097613296009
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,23277,174,0.75 [0.46-1.23],0.2571457842000778
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,24521,147,1.00 [0.59-1.68],0.9918441959927
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",23219,116,1.88 [1.22-2.90],0.004480542318572
CLSTN3,Calsyntenin-3,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,24522,110,1.21 [0.68-2.13],0.5201959364019817
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,21517,120,1.17 [0.68-2.01],0.5743200055508613
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,22898,4155,0.95 [0.87-1.05],0.3347183623611317
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,21698,2955,0.91 [0.81-1.02],0.0993234822401557
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,21482,85,1.00 [0.51-1.96],0.998227304200946
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,22012,136,0.74 [0.43-1.28],0.2852471976531288
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,22020,144,0.99 [0.60-1.66],0.9782370848712147
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,24344,108,1.22 [0.70-2.14],0.4865736000675863
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",21919,43,0.65 [0.24-1.73],0.3834509714179916
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19417,674,0.92 [0.72-1.18],0.5069394475194442
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",24498,114,1.18 [0.66-2.09],0.5734414338998253
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,22135,259,0.86 [0.58-1.27],0.4365729404671085
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,21446,5568,0.96 [0.88-1.04],0.297380819889097
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,23293,101,1.77 [1.07-2.91],0.0252751595712416
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,21507,110,1.27 [0.73-2.21],0.3995754754736816
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21952,555,0.87 [0.67-1.14],0.3186435718458422
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23754,1878,0.98 [0.85-1.13],0.8187662096899251
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,21601,204,1.06 [0.68-1.64],0.8039941460472572
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,21660,263,1.07 [0.75-1.54],0.6979105975172274
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,21535,138,0.63 [0.36-1.08],0.0952920616959211
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,24071,35,0.60 [0.20-1.78],0.3608816237543341
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,19911,1168,0.84 [0.70-1.01],0.0670338200998939
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,19087,344,1.19 [0.85-1.67],0.314611879322153
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",24504,334,1.28 [0.91-1.80],0.1532375834665948
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18809,66,0.41 [0.18-0.92],0.0305544327520328
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),19057,314,0.66 [0.46-0.95],0.0238893355590721
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,21691,294,1.07 [0.75-1.52],0.7218252139956662
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19426,683,0.99 [0.78-1.26],0.9204307947515408
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,21901,25,1.88 [0.76-4.68],0.1729414326914813
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,22376,500,1.24 [0.96-1.61],0.1055305668087456
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,22132,256,0.99 [0.67-1.45],0.9565806251337065
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19375,632,0.90 [0.70-1.16],0.414335920578684
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,21468,71,0.95 [0.46-1.97],0.8870339167022219
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",21451,54,1.17 [0.53-2.59],0.6949159327784229
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,23246,54,1.31 [0.60-2.88],0.4960140671131552
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,24255,1063,1.20 [1.00-1.44],0.0538374714263667
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23795,603,1.12 [0.87-1.44],0.3725056670244574
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",24446,308,1.38 [1.00-1.90],0.046816232904337
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,20351,1608,0.99 [0.85-1.16],0.9050809172364124
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18810,67,0.49 [0.22-1.08],0.0763179452480725
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,21468,71,0.96 [0.46-1.97],0.9023768088539208
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18769,26,2.12 [0.82-5.50],0.1217661160281583
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18845,102,0.91 [0.48-1.70],0.7610380045880096
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,23408,216,1.09 [0.72-1.65],0.6828152012254647
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,23416,224,1.28 [0.87-1.89],0.2096678609734395
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,24518,77,1.89 [1.11-3.20],0.0183115217498385
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",23275,1399,1.02 [0.87-1.20],0.7935788092110968
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,21506,109,0.78 [0.43-1.43],0.4287263823389309
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18856,113,0.94 [0.52-1.69],0.8289674716061018
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,22445,569,1.15 [0.90-1.48],0.2654596753852122
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20575,1832,0.90 [0.78-1.05],0.1718316184059184
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,24089,53,1.24 [0.55-2.82],0.601143232448927
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,24529,71,1.51 [0.80-2.84],0.1999681204031325
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,21466,69,1.12 [0.54-2.33],0.7580903629393493
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",22388,991,1.19 [0.99-1.44],0.0679318195367242
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,21460,63,1.27 [0.61-2.61],0.5217109841335832
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,19753,1010,0.94 [0.77-1.15],0.547236045372486
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,23290,98,0.76 [0.40-1.44],0.3957504505721578
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,21456,59,0.77 [0.33-1.77],0.5396594905856475
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,21980,104,0.82 [0.44-1.51],0.5210748109133797
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21753,356,1.51 [1.13-2.02],0.0057755707615068
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,24227,191,2.16 [1.60-2.91],4.148868206433962e-07
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,22303,427,1.23 [0.93-1.63],0.1413776383932651
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,24455,293,1.45 [1.05-1.99],0.0226772024889232
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,24538,34,2.27 [1.14-4.50],0.0194491096021371
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,21586,189,1.24 [0.80-1.92],0.3370630464242318
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19676,550,1.06 [0.82-1.37],0.656899330794543
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21847,450,1.06 [0.79-1.41],0.7072771952533005
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],21548,151,1.10 [0.66-1.83],0.727511217643804
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18778,35,1.38 [0.54-3.54],0.5015159380499848
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,20328,1585,1.08 [0.93-1.26],0.3015035303621693
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19147,404,0.85 [0.62-1.17],0.3236641761148457
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,24114,78,2.00 [1.11-3.61],0.0209209565678681
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",24486,45,2.27 [1.32-3.93],0.0032266507517736
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",23116,26,0.52 [0.15-1.85],0.3146802870927069
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18816,73,1.62 [0.90-2.92],0.1110553471805535
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,21960,84,0.92 [0.47-1.81],0.8044005614033689
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19055,312,1.39 [1.01-1.91],0.0407272690046998
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,21641,244,1.00 [0.67-1.48],0.9823478452182632
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,22072,196,0.70 [0.44-1.10],0.1173795108415247
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,21971,95,0.89 [0.47-1.71],0.7344672339029478
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20751,41,0.63 [0.23-1.73],0.3675454196346496
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",24541,37,2.36 [1.25-4.46],0.0082399857650577
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21935,538,1.08 [0.83-1.41],0.5643253465175886
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],24115,79,2.50 [1.75-3.58],5.233798395740611e-07
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,23581,2184,1.02 [0.89-1.16],0.7788079542934855
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",21498,101,0.45 [0.24-0.84],0.0118736173105947
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,22204,328,1.10 [0.79-1.54],0.5652433654026194
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,23280,170,1.05 [0.65-1.69],0.838568501243035
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,22012,136,0.73 [0.43-1.26],0.2635702726870075
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22839,963,0.98 [0.81-1.20],0.8788554845705936
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,22506,630,0.90 [0.70-1.15],0.4126261829817716
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],21437,40,0.92 [0.35-2.43],0.8684141106602958
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,24181,145,2.34 [1.80-3.05],2.546214960854888e-10
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,21537,140,0.77 [0.45-1.32],0.3421611292496714
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,21451,54,0.86 [0.37-2.00],0.7243216011326858
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18777,34,0.73 [0.24-2.21],0.5768348068711847
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24089,753,1.91 [1.59-2.28],1.8594992404758104e-12
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),9964,65,0.89 [0.41-1.92],0.7648391339858338
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,13257,72,1.23 [0.64-2.36],0.5406367803599403
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,24292,276,1.33 [0.93-1.90],0.1124941300814022
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,24071,55,1.04 [0.45-2.44],0.9218932119846568
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23902,566,1.82 [1.46-2.27],7.699560829991404e-08
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,24390,18,1.72 [0.57-5.18],0.338829089953405
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,24402,162,1.72 [1.13-2.62],0.0112238494723258
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Cystitis,22552,138,1.27 [0.78-2.07],0.3439792159617467
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Dialysis,23379,43,2.13 [1.14-4.01],0.0185344437587535
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,10620,1009,1.02 [0.84-1.25],0.8296351357962439
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Disorders of breast,13363,178,1.26 [0.83-1.92],0.2740281934041763
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Endometriosis,10016,117,1.22 [0.72-2.04],0.4605094003555378
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",10239,340,0.73 [0.52-1.02],0.0678760461588386
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,10284,385,0.63 [0.45-0.87],0.0049937974765477
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,20705,3780,1.05 [0.95-1.16],0.3609894282897326
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24431,59,2.74 [1.80-4.19],3.0294488005632898e-06
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hydrocele,9683,72,1.02 [0.48-2.15],0.9612278259329292
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,23252,193,1.57 [1.05-2.34],0.0288554633732378
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,10284,673,1.01 [0.79-1.29],0.9217883822114824
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,13245,214,1.38 [0.95-2.01],0.0915732975023205
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),9704,93,0.87 [0.45-1.69],0.6817588402930577
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Irregular menses,13251,110,0.55 [0.30-0.99],0.0459367755512873
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Menorrhagia,10164,265,0.92 [0.63-1.34],0.6694755832949957
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,22472,58,0.80 [0.35-1.83],0.5906467729441436
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,11153,1254,0.75 [0.63-0.89],0.0013564253771746
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,9658,47,1.28 [0.52-3.15],0.5846883919689403
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,9984,85,0.56 [0.28-1.11],0.0952038145453485
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",24544,36,1.82 [0.77-4.30],0.1729925600225721
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",24549,42,1.50 [0.66-3.42],0.3355267712651399
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23777,1363,1.16 [0.99-1.37],0.0736666884542316
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,22840,426,1.11 [0.82-1.50],0.4935454575744465
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,13241,56,0.83 [0.36-1.92],0.6698194190128225
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,24507,267,1.57 [1.11-2.21],0.0099901046532965
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,9753,142,1.03 [0.60-1.75],0.9266151113315144
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,9716,105,1.09 [0.59-2.00],0.7924896739813476
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,9678,67,0.47 [0.22-1.04],0.0639323819869413
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,24520,48,0.77 [0.48-1.23],0.2737818034812692
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,23416,1002,1.34 [1.12-1.61],0.0012666438247498
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,13140,109,1.79 [1.15-2.77],0.0094613072512826
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,9972,73,0.68 [0.32-1.43],0.3057301864648372
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",10106,207,0.69 [0.44-1.06],0.0924782402195909
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,9952,53,0.76 [0.32-1.82],0.5362853624999113
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,9994,95,0.74 [0.39-1.42],0.3700676063400927
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,23284,225,1.45 [0.99-2.13],0.0542743502684188
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,24332,92,1.25 [0.67-2.34],0.4774351795009448
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,10061,162,0.95 [0.58-1.54],0.8292985176983902
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,9969,70,0.79 [0.37-1.65],0.5272792121935943
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,10274,375,0.73 [0.53-1.02],0.0642706408313692
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,9958,59,1.08 [0.49-2.41],0.8450995827921035
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,10231,332,0.67 [0.48-0.96],0.0266669828702658
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,24413,41,2.29 [1.24-4.21],0.007742840550925
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",9708,97,0.93 [0.49-1.78],0.8348087026065023
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24392,1333,1.74 [1.51-2.01],3.2700538363000947e-14
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",23184,125,2.21 [1.59-3.06],2.0445688683252988e-06
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,23396,60,1.09 [0.50-2.37],0.8357185741077834
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,24076,60,1.43 [0.69-2.97],0.3322564263418368
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urethral stricture,22567,153,1.06 [0.64-1.75],0.8131808338260293
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Urolithiasis,24349,333,1.33 [0.96-1.84],0.0884763454821318
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Uterine polyps,9985,86,0.85 [0.43-1.67],0.6361671232387831
